HY-W017500-5g
|
MedChemexpress LLC
|
N-Methyl-DL-aspartic acid [CAS 17833-53-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-12840-10mg
|
MedChemexpress LLC
|
OBA-09 [CAS 856095-68-6]
|
|
Neuroscience-Neurodegeneration
|
|
HY-12840-5mg
|
MedChemexpress LLC
|
OBA-09 [CAS 856095-68-6]
|
|
Neuroscience-Neurodegeneration
|
|
HY-12840-1mL
|
MedChemexpress LLC
|
OBA-09 [CAS 856095-68-6] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0585-1g
|
MedChemexpress LLC
|
Piracetam [CAS 7491-74-9]
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0585-5g
|
MedChemexpress LLC
|
Piracetam [CAS 7491-74-9]
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0585-500mg
|
MedChemexpress LLC
|
Piracetam [CAS 7491-74-9]
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0585-1mL
|
MedChemexpress LLC
|
Piracetam [CAS 7491-74-9] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0336-100mg
|
MedChemexpress LLC
|
Pranoprofen [CAS 52549-17-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0336-50mg
|
MedChemexpress LLC
|
Pranoprofen [CAS 52549-17-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0336-1mL
|
MedChemexpress LLC
|
Pranoprofen [CAS 52549-17-4] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-N0294-1g
|
MedChemexpress LLC
|
Protocatechuic acid [CAS 99-50-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N0294-200mg
|
MedChemexpress LLC
|
Protocatechuic acid [CAS 99-50-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N0294-1mL
|
MedChemexpress LLC
|
Protocatechuic acid [CAS 99-50-3] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-N6939-10mg
|
MedChemexpress LLC
|
Pseudolaric Acid B [CAS 82508-31-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N6939-100mg
|
MedChemexpress LLC
|
Pseudolaric Acid B [CAS 82508-31-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N6939-5mg
|
MedChemexpress LLC
|
Pseudolaric Acid B [CAS 82508-31-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N6939-50mg
|
MedChemexpress LLC
|
Pseudolaric Acid B [CAS 82508-31-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N6939-1mL
|
MedChemexpress LLC
|
Pseudolaric Acid B [CAS 82508-31-4] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99399-1mg
|
MedChemexpress LLC
|
Semorinemab [CAS 2159141-27-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99399-10mg
|
MedChemexpress LLC
|
Semorinemab [CAS 2159141-27-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99399-5mg
|
MedChemexpress LLC
|
Semorinemab [CAS 2159141-27-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100921-10mg
|
MedChemexpress LLC
|
Spaglumic Acid [CAS 3106-85-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100921-100mg
|
MedChemexpress LLC
|
Spaglumic Acid [CAS 3106-85-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100921-5mg
|
MedChemexpress LLC
|
Spaglumic Acid [CAS 3106-85-2]
|
|
Neuroscience-Neurodegeneration
|
|